Global Biologics Outsourcing Formulation Services Market Research Report 2024

Publication ID:

PB508243794

Publication Date:

August 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Biologics Outsourcing Formulation Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biologics Outsourcing Formulation Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics Outsourcing Formulation Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics Outsourcing Formulation Services in Stem Cell Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics Outsourcing Formulation Services include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Outsourcing Formulation Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Outsourcing Formulation Services.
Report Scope
The Biologics Outsourcing Formulation Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Outsourcing Formulation Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Outsourcing Formulation Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Segment by Application
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Outsourcing Formulation Services companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Outsourcing Formulation Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Analytical Testing
1.2.3 Process Development
1.2.4 Cell Development
1.2.5 cGMP Manufacturing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biologics Outsourcing Formulation Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Stem Cell Research
1.3.3 Vaccine Development
1.3.4 Tissue Related Products Development
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Outsourcing Formulation Services Market Perspective (2019-2030)
2.2 Biologics Outsourcing Formulation Services Growth Trends by Region
2.2.1 Global Biologics Outsourcing Formulation Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Outsourcing Formulation Services Historic Market Size by Region (2019-2024)
2.2.3 Biologics Outsourcing Formulation Services Forecasted Market Size by Region (2025-2030)
2.3 Biologics Outsourcing Formulation Services Market Dynamics
2.3.1 Biologics Outsourcing Formulation Services Industry Trends
2.3.2 Biologics Outsourcing Formulation Services Market Drivers
2.3.3 Biologics Outsourcing Formulation Services Market Challenges
2.3.4 Biologics Outsourcing Formulation Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Outsourcing Formulation Services Players by Revenue
3.1.1 Global Top Biologics Outsourcing Formulation Services Players by Revenue (2019-2024)
3.1.2 Global Biologics Outsourcing Formulation Services Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Outsourcing Formulation Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Outsourcing Formulation Services Revenue
3.4 Global Biologics Outsourcing Formulation Services Market Concentration Ratio
3.4.1 Global Biologics Outsourcing Formulation Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Outsourcing Formulation Services Revenue in 2023
3.5 Biologics Outsourcing Formulation Services Key Players Head office and Area Served
3.6 Key Players Biologics Outsourcing Formulation Services Product Solution and Service
3.7 Date of Enter into Biologics Outsourcing Formulation Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Outsourcing Formulation Services Breakdown Data by Type
4.1 Global Biologics Outsourcing Formulation Services Historic Market Size by Type (2019-2024)
4.2 Global Biologics Outsourcing Formulation Services Forecasted Market Size by Type (2025-2030)
5 Biologics Outsourcing Formulation Services Breakdown Data by Application
5.1 Global Biologics Outsourcing Formulation Services Historic Market Size by Application (2019-2024)
5.2 Global Biologics Outsourcing Formulation Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Outsourcing Formulation Services Market Size (2019-2030)
6.2 North America Biologics Outsourcing Formulation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Outsourcing Formulation Services Market Size by Country (2019-2024)
6.4 North America Biologics Outsourcing Formulation Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Outsourcing Formulation Services Market Size (2019-2030)
7.2 Europe Biologics Outsourcing Formulation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Outsourcing Formulation Services Market Size by Country (2019-2024)
7.4 Europe Biologics Outsourcing Formulation Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Outsourcing Formulation Services Market Size (2019-2030)
8.2 Asia-Pacific Biologics Outsourcing Formulation Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Outsourcing Formulation Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Outsourcing Formulation Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Outsourcing Formulation Services Market Size (2019-2030)
9.2 Latin America Biologics Outsourcing Formulation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Outsourcing Formulation Services Market Size by Country (2019-2024)
9.4 Latin America Biologics Outsourcing Formulation Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Outsourcing Formulation Services Market Size (2019-2030)
10.2 Middle East & Africa Biologics Outsourcing Formulation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Outsourcing Formulation Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Outsourcing Formulation Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AtbbVie
11.1.1 AtbbVie Company Detail
11.1.2 AtbbVie Business Overview
11.1.3 AtbbVie Biologics Outsourcing Formulation Services Introduction
11.1.4 AtbbVie Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.1.5 AtbbVie Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Biologics Outsourcing Formulation Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Boehringer Ingelheim International
11.3.1 Boehringer Ingelheim International Company Detail
11.3.2 Boehringer Ingelheim International Business Overview
11.3.3 Boehringer Ingelheim International Biologics Outsourcing Formulation Services Introduction
11.3.4 Boehringer Ingelheim International Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.3.5 Boehringer Ingelheim International Recent Development
11.4 GenScript
11.4.1 GenScript Company Detail
11.4.2 GenScript Business Overview
11.4.3 GenScript Biologics Outsourcing Formulation Services Introduction
11.4.4 GenScript Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.4.5 GenScript Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Biologics Outsourcing Formulation Services Introduction
11.5.4 Merck Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Detail
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Biologics Outsourcing Formulation Services Introduction
11.6.4 Lonza Group Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.6.5 Lonza Group Recent Development
11.7 Catalent
11.7.1 Catalent Company Detail
11.7.2 Catalent Business Overview
11.7.3 Catalent Biologics Outsourcing Formulation Services Introduction
11.7.4 Catalent Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.7.5 Catalent Recent Development
11.8 Innovent Biologics
11.8.1 Innovent Biologics Company Detail
11.8.2 Innovent Biologics Business Overview
11.8.3 Innovent Biologics Biologics Outsourcing Formulation Services Introduction
11.8.4 Innovent Biologics Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.8.5 Innovent Biologics Recent Development
11.9 Syngene
11.9.1 Syngene Company Detail
11.9.2 Syngene Business Overview
11.9.3 Syngene Biologics Outsourcing Formulation Services Introduction
11.9.4 Syngene Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.9.5 Syngene Recent Development
11.10 Shanghai Medicilon
11.10.1 Shanghai Medicilon Company Detail
11.10.2 Shanghai Medicilon Business Overview
11.10.3 Shanghai Medicilon Biologics Outsourcing Formulation Services Introduction
11.10.4 Shanghai Medicilon Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.10.5 Shanghai Medicilon Recent Development
11.11 GL Biochem Corporation
11.11.1 GL Biochem Corporation Company Detail
11.11.2 GL Biochem Corporation Business Overview
11.11.3 GL Biochem Corporation Biologics Outsourcing Formulation Services Introduction
11.11.4 GL Biochem Corporation Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.11.5 GL Biochem Corporation Recent Development
11.12 GVK Biosciences Private
11.12.1 GVK Biosciences Private Company Detail
11.12.2 GVK Biosciences Private Business Overview
11.12.3 GVK Biosciences Private Biologics Outsourcing Formulation Services Introduction
11.12.4 GVK Biosciences Private Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.12.5 GVK Biosciences Private Recent Development
11.13 Horizon Discovery Group
11.13.1 Horizon Discovery Group Company Detail
11.13.2 Horizon Discovery Group Business Overview
11.13.3 Horizon Discovery Group Biologics Outsourcing Formulation Services Introduction
11.13.4 Horizon Discovery Group Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.13.5 Horizon Discovery Group Recent Development
11.14 Selexis
11.14.1 Selexis Company Detail
11.14.2 Selexis Business Overview
11.14.3 Selexis Biologics Outsourcing Formulation Services Introduction
11.14.4 Selexis Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.14.5 Selexis Recent Development
11.15 Abzena
11.15.1 Abzena Company Detail
11.15.2 Abzena Business Overview
11.15.3 Abzena Biologics Outsourcing Formulation Services Introduction
11.15.4 Abzena Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.15.5 Abzena Recent Development
11.16 Adimab
11.16.1 Adimab Company Detail
11.16.2 Adimab Business Overview
11.16.3 Adimab Biologics Outsourcing Formulation Services Introduction
11.16.4 Adimab Revenue in Biologics Outsourcing Formulation Services Business (2019-2024)
11.16.5 Adimab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂